Literatür Detay Bilgisi
brutinib approved for mantle cell lymphoma.

Yayın : Cancer Discov

Yayın Yılı : 2014

Pubmed Linki : http://www.ncbi.nlm.nih.gov/pubmed/24402946

Konu : Lenfoma

Literatür İçeriği :  Abstract

The U.S. Food and Drug Administration (FDA) approved the targeted therapy ibrutinib for treating patients with mantle cell lymphoma who have received at least one prior therapy. The drug is the second designated by the FDA as a "breakthrough therapy" to be granted approval by the agency.

 
 


Literatür Arşivi

Konusu Aynı Olan Diğer Materyaller
SunumlarVideolarOlgu Tartışması